Olink Holding AB Sponsored ADR OLK 深 沪
已收盘 07-10 16:00:00 美东时间
26.08
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 26.08
- 总市值 323.39万
- 52周最高 26.09
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 14.10
- 委 比 0.00%
- 总股本 0.00亿
- 历史最高 42.20
- 量 比 0
- 振 幅 0.00%
- 历史最低 8.39
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Seer Files Definitive Proxy Materials and Mails Letter to Stockholders
Seer, Inc. has filed definitive proxy materials for its 2026 Annual Meeting of Stockholders, urging shareholders to vote for its seven highly qualified director nominees on the BLUE proxy card. The company highlights its clear strategy to build the market for deep, unbiased proteomics, disciplined financial management, and the strong qualifications of its Board of Directors. Seer strongly opposes Bradley Radoff and Michael Torok’s proxy fight, ar...
06-03 22:00
Seer to Showcase AI-Driven Multi-Cancer Screening Approach and Next-Generation Proteomics Capabilities at ASMS 2026
Seer, Inc. will showcase its Proteograph Product Suite at the 2026 ASMS conference, highlighting advancements in AI-driven proteomics for multi-cancer screening and scalable data processing. The company will present findings from a 20,000-sample collaboration with Korea University, demonstrating how deep plasma proteomics can enhance early cancer detection. Additionally, Seer will introduce Radiant DIA and Fulcrum Pipeline, tools designed to acce...
05-26 20:05
Seer Announces Nonbinding Takeover Proposal From Shareholder Radoff-JEC Group At $2.35 Per Share In Cash Plus One Contingent Value Right
Dear Members of the Board,As you are aware, Bradley L. Radoff and Michael Torok (together with certain of their affiliates, the "Radoff-JEC Group" or "we") are significant stockholders of Seer, Inc. ("Seer" or the
04-24 19:03
Seer Joins Thermo Fisher Tools In Large-Scale Proteomics Effort
Seer Proteograph platform joins Singapore study to profile 10,000 samples, integrating data for disease research and risk modeling.
04-09 20:01
Nautilus Biotechnology names Amber Faust vice president of sales
Nautilus Biotechnology names Amber Faust vice president of sales Nautilus Biotechnology Inc. appointed Amber Faust as Vice President of Sales. Faust, a proteomics commercial leader with prior roles at Olink Proteomics, SomaLogic, and Waters Corporation, will lead sales efforts tied to the Nautilus V
03-02 21:03
Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales
Nautilus Biotechnology has appointed Amber Faust as Vice President of Sales to drive the commercialization of its Voyager Platform, a revolutionary proteomics technology. With nearly two decades of experience in proteomics, Faust will lead the platform's market introduction, including securing pre-orders and expanding market reach. Nautilus recently launched the Voyager Platform, designed for single-molecule proteome analysis, and initiated the I...
03-02 13:00
Olink×联川生物×华大智造丨全球首次Reveal真实样本测序丝滑上岸！
近日，Olink与华大智造联合完成了Olink Reveal高通量蛋白质检测产品在T1+和2000测序平台上的系列验证实验。该实验涵盖了从文库构建到数据产出的全...
2025-11-10 17:48
Thermo Fisher Scientific Reports Strong Q4 2024 Earnings with 5% Revenue Growth and 14% Increase in GAAP EPS
WALTHAM, Mass. (January 30, 2025) - Thermo Fisher Scientific Inc. (NYSE: TMO), a global leader in serving science, reported its financial results for the fourth quarter and full year ended December 31...
2025-01-30 19:05
